Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tumor Antigen-sensitized DC Vaccine as an Adjuvant Therapy for R0 Resection of Colorectal Cancer Liver Metastases

NCT06545630 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT06545630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06545630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tumor Antigen-sensitized DC Vaccine as an Adjuvant Therapy for R0 Resection of Colorectal Cancer Liver Metastases
Lead sponsor
West China Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
November 1, 2023
Completion date
May 31, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, colorectal cancer